Cleared Traditional

K220869 - Vapotherm Aerosol Adapter AAA-2

K220869 is an FDA 510(k) clearance for Vapotherm Aerosol Adapter AAA-2, manufactured by Vapotherm, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 217-day FDA review.

K220869 · Vapotherm, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
217d
Days
Class 2
Risk

K220869 is an FDA 510(k) clearance for the Vapotherm Aerosol Adapter AAA-2. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Vapotherm, Inc. (Exeter, US). The FDA issued a Cleared decision on October 28, 2022 after a review of 217 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vapotherm, Inc. devices

FDA 510(k) Submission Details - K220869

510(k) Number K220869 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2022
Decision Date October 28, 2022
Days to Decision 217 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 140d · This submission: 217d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 190
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K220869.
Hudson RCI AquaTherm III Plus External Adjustable Electronic Heater (050-14)
K223100 · Medline Industries, Inc. · Jun 2023
Hudson RCI Variable concentration Large Volume Nebulizer (1770)
K220955 · Medline Industires, Inc. · Jun 2023
Hailie Sensor NF0110
K222247 · Adherium (Nz), Ltd. · Feb 2023
Hailie Sensor NF0107 & NF0108
K221994 · Adherium (Nz), Ltd. · Oct 2022
Hailie Sensor NF0106
K220622 · Adherium (Nz), Ltd. · Jul 2022
Nebulizer
K212395 · Shenzhen Homed Medical Device Co., Ltd. · Mar 2022